![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/01/GettyImages-643707544-e1738236103619.jpg)
MHRA launches refreshed ILAP to speed up NHS drug access
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a refreshed Innovative Licensing and Access Pathway (ILAP) to accelerate patient access to new medicines by integrating regulatory and health technology assessment procedures …